Cadence Solutions Revenue, Valuation, Funding & Investors

Cadence Solutions is valued at $1.2B as of June 2026.

Last Cadence Solutions valuation

$1.2B

Series C · Jun 2026

Last Cadence Solutions funding round

$100M

Series C · Jun 2026

Cadence Solutions revenue

$35M

Series B · Dec 2021

Key investors in Cadence Solutions

  • General Catalyst
  • Thrive Capital
  • Coatue
  • Spark Capital
  • B Capital
  • K5 Global

Cadence Solutions Overview

About Cadence Solutions

Cadence is a health technology company enabling virtual and in-home care programs for major US health systems including Intermountain Healthcare and CommonSpirit Health. Headquartered in San Francisco, its platform coordinates post-acute care, chronic disease management, and transitional care through nurse-led teams, telehealth, and data analytics to reduce readmissions.


Founded

2020

HQ

United StatesNew York City, NY

Status

Privately held

Customer focus

B2B

Revenue model

Subscription

Revenue

$35M (Dec 2021)

Valuation

$1.2B (Jun 2026)

Cadence Solutions Valuation

Cadence Solutions is currently valued at $1.2B, based on its Series C in June 2026.

The $100M round was led by Spark Capital, with participation from General Catalyst, Corewell Health Ventures, Memorial Hermann Hospital, B Capital, Thrive Capital and 2 other investors.

Cadence Solutions' valuation has grown 1.2x from $1B at its Series B in December 2021 to $1.2B in June 2026, across 2 priced rounds.

Cadence Solutions valuation by funding round

Revenue multiple
Cadence Solutions valuation by funding round
DateStageValuationRevenue Multiple
Jun 2026Series C$1.2B-
Dec 2021Series B$1B28.6x

Cadence Solutions Revenue

Cadence Solutions' latest recorded revenue is $35M, as of its Series B in December 2021. At a $1B valuation, that implies a 28.6x revenue multiple.

Cadence Solutions revenue by funding round

Cadence Solutions revenue and valuation multiple by funding round
DateRevenue *ValuationRevenue MultipleStage
Dec 2021$35M$1B28.6xSeries B

* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.

Cadence Solutions Funding History

Cadence Solutions has raised a total of $241M across 3 funding rounds.

Cadence Solutions' first fundraising round was a $41M Series A in August 2021. The most recent completed round was a $100M Series C in June 2026.

Cadence Solutions funding rounds

Cadence Solutions funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Jun 2026Series CSpark Capital (lead); General Catalyst; Corewell Health Ventures; Memorial Hermann Hospital; B Capital; Thrive Capital; Coatue; Duke Health$100M$1.2BCadence, a New York-based clinical AI startup automating chronic care for older adults, raised $100 million in a Series C round on June 23, 2026, led by Spark Capital, achieving a post-money valuation of $1.2 billion. The round included participation from Thrive Capital, General Catalyst, Coatue, B Capital, and venture arms of Corewell Health, Memorial Hermann, and Duke Health, bringing total funding to $243.46 million. Strategically, the capital will scale AI agents to serve over 56 million older adults with chronic diseases, expand across new health systems, advance AI capabilities, and grow value-based care models, transitioning from remote monitoring billing to a regulated-AI platform for hypertension, diabetes, and heart failure. Cadence, founded by Chris Altchek, previously emerged from stealth with $41 million and a partnership with LifePoint Health, and its Series A was led by Thrive Capital.
Dec 2021Series BCoatue (lead); K5 Global; General Catalyst; Thrive Capital$100M$1BCadence Solutions is a digital health company providing a remote patient monitoring (RPM) and virtual care platform designed to manage chronic conditions such as COPD, hypertension, heart failure, and Type 2 diabetes. The platform uses connected devices to track patient vitals including heart rate, blood pressure, blood glucose, and weight, enabling providers to adjust care plans, facilitate clinician-patient communication via calls, texts, or telehealth, and deliver guideline-directed medical therapy, particularly for rural patients. On December 14, 2021, Cadence raised $100 million in a Series B funding round led by Coatue Management, with participation from existing investors General Catalyst, Thrive Capital, and K5 Global. This round boosted the company's post-money valuation to $1 billion, following an earlier $41 million seed round in August 2021 at a lower valuation. Forge Global lists the Series B amount as $115 million with a price per share of $4.60 and 24,992,394 shares outstanding, confirming the $1B post-money valuation. The funding aims to scale operations, accelerate hiring (targeting 155 clinicians by July 2022), expand partnerships with health systems like LifePoint Health, and broaden support for additional conditions and care pathways amid growing demand for home-based care post-pandemic. CEO Chris Altchek emphasized building innovative digital infrastructure to reduce care disparities and lower costs by treating conditions at home. Cadence operates in the fast-growing RPM and virtual care market, where chronic disease management is critical, as six in ten U.S. adults have at least one chronic condition per CDC estimates. Competitors include Current Health (acquired by Best Buy), Biobeat, and OnSky Health. Investors like Coatue's Aaron Weiner highlighted Cadence's potential to transform healthcare access regardless of location.
Aug 2021Series AGeneral Catalyst (lead); Thrive Capital (lead); Hugo Barra; Adam Boehler; Metrodora Ventures; Martin Ventures$41M-Cadence Solutions is a health technology company based in New York that helps health systems deliver personalized care outside hospitals using machine learning to analyze patient vitals for real-time disease management. The company has raised total funding of $141.9 million across three rounds, with a most recent funding amount listed as $100 million. A later Series B round of $100 million was led by Coatue Management, with participation from existing investors General Catalyst and Thrive Capital, aimed at building infrastructure for health systems to support virtual care post-pandemic.

Who has invested in Cadence Solutions?

13 investors have backed Cadence Solutions across its funding rounds, including General Catalyst, Thrive Capital, Coatue, Spark Capital, B Capital and K5 Global.

Lead investors include Spark Capital, Coatue, General Catalyst and Thrive Capital.


Cadence Solutions Investors

Investors in Cadence Solutions by funding rounds participated
InvestorHQRoundsRoleFirst check
General CatalystUnited StatesSan Francisco, CA3LeadAug 2021
Thrive CapitalUnited StatesNew York City, NY3LeadAug 2021
CoatueUnited StatesNew York City, NY2LeadDec 2021
K5 GlobalUnited StatesSan Francisco, CA1ParticipantDec 2021
Hugo BarraUnited StatesSan Francisco, CA1ParticipantAug 2021
Corewell Health Ventures--1ParticipantJun 2026
Spark CapitalUnited StatesSan Francisco, CA1LeadJun 2026
Adam BoehlerUnited StatesNashville, TN1ParticipantAug 2021
Memorial Hermann HospitalUnited StatesHouston, TX1ParticipantJun 2026
Metrodora VenturesUnited StatesNew York City, NY1ParticipantAug 2021
B CapitalUnited StatesLos Angeles, CA1ParticipantJun 2026

This data is available for Pro users. Sign up to see all 13 Cadence Solutions investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Cadence Solutions Competitors

Cadence Solutions competitors include listed companies like Guiyang Longmaster and Medley Inc., and private ones like Assort Health, Tala Health, Wheel and League.

Public and private companies comparable to Cadence Solutions
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Assort HealthUnited StatesSan Francisco, CAPrivate$3M-$1.2B-
Tala HealthUnited StatesSan Francisco, CAPrivate--$1.2B-
WheelUnited StatesAustin, TXPrivate--$1.2B-
LeagueCanadaTorontoPrivate--$1.2B-
Guiyang LongmasterChinaChinaPublicly listed$44M$5M$482M-
Medley Inc.JapanJapanPublicly listed$236M$32M$459M1.8x

Cadence Solutions Public Comps

Cadence Solutions is still privately-owned, but its public comps include U.S. Physical Therapy, GoodRx, Teladoc, EverCommerce, PHC Holdings, Vitec Software, iFLYHealth, Indegene, Omnicell and JMDC.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
U.S. Physical Therapy$781M$110M2.5x2.3x17.5x18.9x
GoodRx$797M$173M1.8x1.8x8.1x5.5x
Teladoc$2.5B$124M0.6x0.6x11.3x5.0x
EverCommerce$589M$128M3.0x2.9x13.7x9.5x
PHC Holdings$2.3B$320M1.0x1.0x7.2x6.5x
Vitec Software$371M$151M3.7x3.5x9.1x9.0x
iFLYHealth$136M($7M)7.7x6.2x(150.8x)(144172.5x)
Indegene$366M$68M3.7x3.3x19.9x18.2x

This data is available for Pro users. Sign up to see all Cadence Solutions competitors and their valuation data.

Start Free Trial

Common questions about Cadence Solutions

When was Cadence Solutions founded?Cadence Solutions was founded in 2020.
Where is Cadence Solutions headquartered?Cadence Solutions is headquartered in New York City, NY, United States.
Is Cadence Solutions publicly listed?No, Cadence Solutions is a private, VC-backed company.
What is Cadence Solutions' valuation?Cadence Solutions was last valued at $1.2B in its Series C in June 2026.
How much funding has Cadence Solutions raised?Cadence Solutions has raised $241M across 3 funding rounds.
What was Cadence Solutions' last funding round?Cadence Solutions' last funding round was a $100M Series C in June 2026, led by Spark Capital.
Who are Cadence Solutions' investors?Cadence Solutions' investors include General Catalyst, Thrive Capital, Coatue, K5 Global, Hugo Barra, Corewell Health Ventures, Spark Capital, Adam Boehler, Memorial Hermann Hospital, Metrodora Ventures and 3 others.
What is Cadence Solutions' revenue?Cadence Solutions' latest recorded revenue is $35M (December 2021).
What is Cadence Solutions' revenue multiple?Cadence Solutions' latest valuation implies a 28.6x revenue multiple ($1B valuation on $35M of revenue).
Which companies are comparable to Cadence Solutions?Companies comparable to Cadence Solutions include Assort Health, Tala Health, Wheel, League, Guiyang Longmaster and Medley Inc..

See companies similar to Cadence Solutions

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial